Learn how the FDA's 180-day exclusivity works for generic drug applicants, including Paragraph IV certifications, forfeiture risks, and upcoming regulatory changes.
Apr, 16 2026
Jul, 14 2026
Jan, 1 2026
Jan, 26 2026
Nov, 19 2025